Dr. Pagdin Bioidentical Hormone Replacement Therapy for Women
Grant Pagdin, MD. Canadian board-certified in Family Medicine, American Academy of Anti-Aging and Regenerative Medicine (ABAARM). Fellowship in Family Medicine (FCFP). Fellowship in Stem Cell Medicine. Fellow with the Interventional Orthobiologics Foundation.
Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions. BHRT products are prescribed by clinicians and prepared by compounding pharmacies. This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months. Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale. Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.
Quality Improvement, Interventional, Open-Ended
Collaboration with nationally recognized musculoskeletal physicians. Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications. Drive superior patient education and engagement. Legal/regulatory compliance. Support payer negotiations.
Cervantes Short-Form Scale; Heavy Menstrual Bleeding-Visual Analog Scale
Related Posts
Dr. Pagdin Bioidentical Hormone Replacement Therapy for Women
Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions. BHRT products are prescribed by clinicians and prepared by compounding pharmacies. This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months. Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale. Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.
Bioidentical Hormone Replacement Therapy (“BHRT”) is used to help treat female hormonal conditions. BHRT products are prescribed by clinicians and prepared by compounding pharmacies. This Circle captures symptoms and health-related quality-of-life data from pre- and post-administration of BHRT for 18 months. Outcome measures include the Cervantes Short-Form Scale and the Heavy Menstrual Bleeding-Visual Analog Scale. Aggregated Circle datasets will provide clinically significant evidence relating to safety and efficacy of BHRT for female patients.
Clinically significant reduction in scores collected from the Cervantes Short-Form Scale at 6-months post-treatment.
C-SF; HMB-VAS
Endocrinologists, family practice and other primary care physicians, compounding pharmacies, obstetricians- gynecologists, advanced practice nurses and physicians assistants.
Bioidentical Hormone Replacement Therapy (BHRT)
Collaboration with nationally recognized musculoskeletal physicians. Participate and benefit from clinically significant registry datasets supporting standards of care for a variety of musculoskeletal indications. Drive superior patient education and engagement. Legal/regulatory compliance. Support payer negotiations.
Streamlined patient enrollment, real-world data capturing, heightened recognition, prominence and collaboration
CIRCLE LIBRARY
CIRCLE NAME
Total Knee Arthroplasty Outcome-Based Performance Measure
SURVEYS
VAS
KOOS Jr.
VR-12 (compliant with CMS/IQR Requirements)
As specified by Provider
THIS CIRCLE IS FOR:
Provider Receiving CMS Reimbursement For TKAs
CMS will soon penalize providers performing total knee replacements which do not collect specified outcomes data from at least 50% of qualifying patients.
Other Providers Performing TKAs
Private insurance companies and other payers within and outside the U.S. will follow the CMS lead in requiring high patient compliance in reporting long-term TKA outcomes.
WHY CIRCLES
If you have any questions, please contact us.